1. Home
  2. PDFS vs AVXL Comparison

PDFS vs AVXL Comparison

Compare PDFS & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDFS
  • AVXL
  • Stock Information
  • Founded
  • PDFS 1992
  • AVXL 2004
  • Country
  • PDFS United States
  • AVXL United States
  • Employees
  • PDFS N/A
  • AVXL N/A
  • Industry
  • PDFS EDP Services
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PDFS Technology
  • AVXL Health Care
  • Exchange
  • PDFS Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • PDFS 1.0B
  • AVXL 956.7M
  • IPO Year
  • PDFS N/A
  • AVXL N/A
  • Fundamental
  • Price
  • PDFS $25.40
  • AVXL $9.80
  • Analyst Decision
  • PDFS Strong Buy
  • AVXL Strong Buy
  • Analyst Count
  • PDFS 3
  • AVXL 2
  • Target Price
  • PDFS $33.33
  • AVXL $44.00
  • AVG Volume (30 Days)
  • PDFS 335.3K
  • AVXL 1.2M
  • Earning Date
  • PDFS 11-06-2025
  • AVXL 08-12-2025
  • Dividend Yield
  • PDFS N/A
  • AVXL N/A
  • EPS Growth
  • PDFS N/A
  • AVXL N/A
  • EPS
  • PDFS 0.02
  • AVXL N/A
  • Revenue
  • PDFS $196,000,000.00
  • AVXL N/A
  • Revenue This Year
  • PDFS $23.72
  • AVXL N/A
  • Revenue Next Year
  • PDFS $18.44
  • AVXL N/A
  • P/E Ratio
  • PDFS $1,163.64
  • AVXL N/A
  • Revenue Growth
  • PDFS 17.76
  • AVXL N/A
  • 52 Week Low
  • PDFS $15.91
  • AVXL $5.03
  • 52 Week High
  • PDFS $33.42
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • PDFS 61.80
  • AVXL 58.71
  • Support Level
  • PDFS $25.13
  • AVXL $8.80
  • Resistance Level
  • PDFS $27.12
  • AVXL $10.04
  • Average True Range (ATR)
  • PDFS 0.99
  • AVXL 0.49
  • MACD
  • PDFS 0.18
  • AVXL 0.18
  • Stochastic Oscillator
  • PDFS 71.49
  • AVXL 73.79

About PDFS PDF Solutions Inc.

PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: